BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Biotech Beach

  PURE Bioscience to Raise up to $3 Million in Registered Direct Financing

  May 22, 2009

   · 

  1 min read
• Business

  BIOTRONIK to Supply ICD Technology to Cardio3 BioSciences for C-Cure(R) Stem Cell Clinical Trial

  May 22, 2009

   · 

  1 min read
• Biotech Bay

  Xcorporeal, Inc. Reports on Failure to Meet Listing Standards of NYSE AMEX

  May 22, 2009

   · 

  1 min read
• BioCapital

  HHS Takes Additional Steps Toward Development of Vaccine for the Novel Influenza A (H1N1)

  May 22, 2009

   · 

  1 min read
• Specialty Care Costs for Patients with Bipolar Disorder are Higher than Diabetes and Other Chronic Diseases

  May 22, 2009

   · 

  1 min read
• Intensive Glucose Control Reduces MI and CHD-Event Risk, New Meta-Analysis Shows

  May 22, 2009

   · 

  1 min read
• Policy

  Micro Imaging Technology Provides an Update on Litigation Against Divine Capital Markets, LLC

  May 22, 2009

   · 

  5 min read
• Deals

  Simulations Plus Announces Change in Acquisition Status

  May 22, 2009

   · 

  1 min read
• CoreValve System Even Treats Patients with Compromised Peripheral Blood Vessel

  May 22, 2009

   · 

  1 min read
• FDA

  Otsuka Pharmaceutical Co., Ltd.: FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia

  May 22, 2009

   · 

  12 min read